Articles tagged with Adenocarcinomas
MIT researchers have found that lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs, with some tumor cells developing resistance by amplifying the KRAS gene and others changing their tumor type, leading to new insights into treatment resistance and potential targets for new drugs.
Researchers from UT MD Anderson Cancer Center present studies on single-cell technologies, integrative computational approaches, and experimental therapeutics, highlighting innovations in mRNA vaccines and spatial multi-omics techniques. The studies aim to improve immunotherapy responses and detect treatment-resistant glioma cells.
A study published in Oncotarget has identified specific mutational and therapeutic landscapes of pancreatic cancer in the Russian population. By applying machine learning models to full exome individual data, researchers received personalized recommendations for targeted treatment options for each clinical case.
Researchers at Weill Cornell Medicine have developed a mouse model that illuminates the process of histological transformation, where adenocarcinoma transforms into aggressive small cell lung cancer. The study suggests targeting Myc proteins as potential therapeutic approaches for this deadly type of cancer.
Scientists from Tokyo Medical and Dental University created a synthetic polymer biomaterial that mimics the pancreatic adenocarcinoma microenvironment, enabling them to identify potential therapeutic targets. The study successfully recapitulates the complex interactions between cancer stem cells and their niche.
A retrospective study found that tumor hyaluronan levels are associated with improved time to progression in non-small cell lung cancer patients. HA-high tumors showed a trend towards improved clinical benefit, suggesting its potential as a prognostic biomarker and therapeutic target.
A study analyzing 16,083 colorectal biopsies found that 2.65% of rectal adenocarcinoma patients have mismatch repair deficiency, challenging earlier estimates. The analysis also highlighted the importance of screening at all ages for this condition.
A team of researchers at Case Western Reserve University has discovered a cell signaling pathway responsible for the development of esophageal adenocarcinomas. The Ephrin B2 (EphB2) Tyrosine kinase pathway is activated during cancer growth and regulates the behavior of normal esophageal cells, making it an attractive therapeutic target.
A disturbing trend of increasing young-onset gastrointestinal adenocarcinomas has been observed in South Australia over the past three decades, with a significant increase in incidence rates among males aged under 50. Improved survival rates for older adults have not been seen in younger patients, except for those with colorectal cancer.
Researchers analyzed SEER 18 data and found adenocarcinomas to be the predominant cancer subtype in screening, surveillance, and prevention. The study also revealed that carcinoid tumors are increasing at a faster rate than adenocarcinomas, but adenocarcinomas are still steadily increasing in most early-onset subgroups.
A new study reports that cervical adenocarcinoma incidence rates are increasing in non-Hispanic whites, particularly among women aged 40-49 and 50-59. This trend underscores the need for intensified efforts to improve screening utilization and HPV vaccination.
Researchers analyzed 559 esophageal and gastric cancer samples to discover two main types of esophageal cancer differ markedly in molecular characteristics. The study suggests grouping patients according to molecular subtype for more effective clinical trials and new treatment approaches.
A team of investigators identified a subtype of human adenocarcinoma that may be amenable to a new therapy. The research found that tumor suppressing C/EBPα works by restraining the expression of oncogenic protein BMI1, leading to an inverse correlation between the two molecules in NSCLC patients.
A new study reports that a targeted molecular contrast agent can be used to cause lung adenocarcinomas to fluoresce during pulmonary surgery, enabling real-time optical imaging and precise visualization of tumor margins. The technique showed promise in localizing tumors and detecting metastatic cancer cells with high accuracy.